Author

Omid Tavana

AstraZeneca (United States)ORCID 0000-0001-8401-4546Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Assay:ChIP-seq· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

Abhijit ParoliaiD· 1 shared Arul M. ChinnaiyaniD· 1 shared Bingwei WangiD· 1 shared Brijesh Kumar VermaiD· 1 shared Caiyun Hou· 1 shared Chandan Kanta Das· 1 shared Eleanor YoungiD· 1 shared Erick Mitchell-VelasqueziD· 1 shared

Activity by Year

2024-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Abhijit ParoliaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyNature GeneticsPeer-reviewedSep 9, 2024

NSD2 is a requisite subunit of the AR/FOXA1 neo-enhanceosome in promoting prostate tumorigenesis

Abhijit Parolia, Sanjana Eyunni, Brijesh Kumar Verma…·Irfan Ahmed Asangani

This study identifies NSD2 as a critical component of the AR neo-enhanceosome in prostate cancer, showing its role in AR enhancer circuitry and tumor progression.

45 citationstop 2%

humanChIP-seq

𝕏 PostBluesky

Cancer BiologyeLifePeer-reviewedJul 17, 2024

Repression of PRMT activities sensitize homologous recombination-proficient ovarian and breast cancer cells to PARP inhibitor treatment

Youyou Zhang, Mu Xu, Jiao Yuan…·Xiaowen Hu

This study identifies PRMT inhibitors as effective combinational therapies with PARP inhibitors to sensitize HR-proficient ovarian and breast cancer cells to treatment.

8 citations

humanbulk RNA-seq

𝕏 PostBluesky